Stability analysis of a model for HIV infection with RTI and three intracellular delays

BioSystems

Volumn 95, Issue 1, 2009, Pages 1-6

  Ouifki, Rachid ^a   Witten, Gareth ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bifurcation; Delay; Differential equation; HIV; Stability; Treatment

Indexed keywords

RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CYTOLOGY; DISEASE TREATMENT; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS; INHIBITOR; MODELING; NUMERICAL METHOD; STABILITY ANALYSIS; VIRUS;

ARTICLE; COMPUTER PROGRAM; HOPF BIFURCATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACELLULAR DELAY; INTRACELLULAR TRANSPORT; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOLECULAR STABILITY; NONHUMAN; OSCILLATION; STEADY STATE; VIREMIA; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 56849115760     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2008.05.027     Document Type: Article

References (25)

1. Beretta E., and Kuang Y. Geometric stability switch criteria in delay differential systems with delay dependent parameters. SIAM J. Math. Anal. 33 (2002) 1144-1165
2. Cohen-Stuart J.W., Wensing A.M., Kovacs C., Righart M., de Jong D., Kaye S., Schuurman R., Visser C.J., and Boucher C.A. Transient relapses (blips) of plasma HIV RNA levels during hart are associated with drug resistance. J. Acquir. Immune Defic. Syndr. 28 (2001) 105-113
3. Cooke K.L., and van den Driessche P. On zeroes of some transcendental equations. Funkcialaj Ekvacioj 29 (1986) 77-90
4. Culshaw R.V., and Ruan S. A delay-differential equation model of HIV infection of CD4+ T-cells. Math. Biosci. 165 (2000) 27-39
5. Diekmann O., van Gils S.A., Lunnel V., and Walther H.-O. Delay Equations: Functional-, Complex-, and Nonlinear Analysis (1995), Springer-Verlag
6. Di Mascio M., Markowitz M., Louie M., Hogan C., Hurley A., Chung C., Ho D.D., and Perelson A.S. Viral blip dynamics during highly active antiretroviral therapy. J. Virol. 77 (2003) 12165-12172
7. Di Mascio M., Ribeiro R.M., Markowitz M., Ho D.D., and Perelson A.S. Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy. Math. Biosci. 188 (2004) 47-62
8. Dixit N.M., and Perelson A.S. Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay. J. Theor. Biol. 226 (2004) 95-109
9. Freedman H.I., and Kuang Y. Stability switches in linear scalar neutral delay equations. Funkcialaj Ekvacioj 34 (1991) 187-209
10. Fung H.B., Stone E.A., and Piacenti F.J. Tenofovir disoproxil fumerate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. Clin. Therap. 24 (2002) 1515-1548
11. Gross I., Hohenberg H., Wilk T., Wiegers K., Grttinger M., Fuller M.B.S., and Krusslich H.G. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19 (2000) 103-113
12. Hassard B.D., Kazarinoff N.D., and Wan Y.H. Theory and Applications of Hopf Bifurcation (1981), Cambridge University, Cambridge
13. Hermankova M., Ray S.C., Ruff C., Powell-Davis M., Ingersoll R., DAquila R.T., Quinn T.C., Siliciano J.D., Siliciano R.F., and Persaud D. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA 286 (2001) 196-207
14. Herz A.V.M., Bonhoeffer S., Anderson R.M., May R.M., and Nowak M.A. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7247-7251
15. Jones L.E., and Perelson A.S. Modeling the effects of vaccination on chronically infected HIV-positive patients. J. Acquir. Immune Defic. Syndr. 31 (2002) 369-377
16. Mittler J.E., Sulzer B., Neumann A.U., and Perelson A.S. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math. Biosci. 152 (1998) 143-163
17. Nelson P.W., Murray J.D., and Perelson A.S. A model of HIV-1 pathogenesis that includes an intracellular delay. Math. Biosci. 163 (2000) 201-215
18. Nelson P.W., and Perelson A.S. Mathematical analysis of delay differential equation models of HIV-1 infection. Math. Biosci. 179 (2002) 73-94
19. Pellegrino M.G., Gongrong L., Potash M.J., and Volsky D.J. Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. J. Biol. Chem. 266 (1991) 1783-1788
20. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., and Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271 (1996) 1582-1586
21. Reddy B., and Yin J. Quantitative intracellular kinetics of HIV type 1. AIDS Res. Hum. Retrovir. 15 (1999) 273-283
22. Robbins B.L., Srinivas R.V., Kim C., Bischofberger N., and Fridland A. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleo-side phosphate 9-r-(2-phosphonomethoxypropyl)adenine (pmpa), bis(isopropyloxymethylcarbonyl)pmpa. Antimicrob. Agents Chemother. 42 (1998) 612-617
23. + T-cell mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3503-3508
24. van't Wout A.B., Lehrman G.K., Mikheeva S.A., O'Keeffe G.C., Katze M.G., Bumgarner R.E., Geiss G.K., and Mullins J.I. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4+ T-cell lines. J. Virol. 77 (2003) 1392-1402
25. Zhou J., Huang L., Hachey D.L., Chen C.H., and Aiken C. Inhibition of HIV-1 maturation via drug association with the viral gag protein in immature HIV-1 particles. J. Biol. Chem. 280 (2005) 42149-42155